MRK Stock Analysis — AI Buy/Sell Signals & Forecast
Real-time AI-powered analysis for MRK with price targets, technical indicators (RSI, MACD, SMA), institutional money flow, and news-based signals.
Unlock Full Pro Analysis
Real-time alerts, price targets, institutional flow & more — one-time $19.95.
MRK · Merck & Co., Inc.
Free summary — full analysis below.
Merck & Co., Inc.
Pre-Market & After Hours is Pro Only
Upgrade to unlock this and all premium features
Oct 8, 05:33 AM
Confidence Score is Pro Only
Upgrade to unlock this and all premium features
Optimal Buy & Sell Zones is Pro Only
Upgrade to unlock this and all premium features
Pullback in Uptrend — Below SMA50 but above SMA200
Total Conviction Scorecard is Pro Only
Upgrade to unlock this and all premium features
Optimal Buy & Sell Zones is Pro Only
Upgrade to unlock this and all premium features
$-14.13 (-9.0%) from high
Day's Range: $141.51 – $144.15
+$60.78 (+74.1%) above low
▼ Below — short-term downtrend (bearish)
▲ Above — long-term uptrend (bullish)
📉 0.6x avg — below normal, treat signals with caution
📉 Below normal — thin market, price moves may not hold
RSI, MACD & SMA based on daily closes — update at market close. Live price shown separately.
Institutional Money Flow is Pro Only
Upgrade to unlock this and all premium features
Phantom Flow is Pro Only
Upgrade to unlock this and all premium features
Smart Money Flow Index is Pro Only
Upgrade to unlock this and all premium features
Risk Score is Pro Only
Upgrade to unlock this and all premium features
Recent legal setbacks regarding Keytruda's subcutaneous patent in the EU introduce near-term regulatory uncertainty for Merck's primary revenue driver. Investors should monitor how these intellectual property challenges impact long-term growth expectations before making significant portfolio moves.
Latest News & Market Impact
Is Exelixis Stock Engineered To Make You Money?
Is Halozyme’s EU Injunction on Subcutaneous Keytruda Reshaping the Investment Case For Merck (MRK)?
Sector Update: Healthcare Stocks Rise Late Afternoon
Merck’s Keytruda Is Dealt a Legal Setback. It’s Good News for This Biotech Stock.
Sector Update: Healthcare Stocks Rise in Afternoon Trading
Disclaimer: This analysis is AI-generated and should not be considered financial advice. Always consult a qualified financial advisor before making investment decisions.
MRK Stock Analysis — Frequently Asked Questions
Is MRK a buy or sell right now?▾
Our AI engine analyzes MRK across technicals (RSI, MACD, SMA50/200), institutional money flow (OBV, SEC 13D/13G filings), news sentiment, and price action to produce a real-time buy/sell signal with a confidence score. The recommendation updates every time the analysis runs.
What is the price target for MRK?▾
The analysis calculates optimal entry and exit price targets for MRK using support/resistance levels, moving-average structure, and momentum. These levels are dynamic and recompute as new market data arrives.
What do the RSI and MACD signals say about MRK?▾
RSI measures whether MRK is overbought or oversold; MACD shows momentum and trend shifts. A bullish MACD crossover with RSI below 70 often signals continued upside, while divergence can warn of a reversal.
Are institutions buying MRK?▾
We track institutional positioning in MRK through On-Balance Volume (OBV) money flow and SEC Schedule 13D/13G filings — the same disclosures activist investors and large funds must file. Rising OBV plus new 13D filings typically indicate smart-money accumulation.
What are the main risks of investing in MRK?▾
Key risks for MRK include valuation compression, sector rotation, earnings volatility, and macro factors such as rates and inflation. The analysis grades risk from very low to very high based on volatility, drawdown history, and beta.
How accurate is the MRK AI analysis?▾
The MRK analysis combines real-time market data, technical indicators, institutional flow, and news-based sentiment. It is a decision-support tool, not financial advice — always do your own research and consider your risk tolerance before investing.
Market Intelligence provides AI-powered stock & ETF analysis for informational purposes only and does not constitute financial advice.